CPT code 81244: FMR1 testing, allele size and methylation2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Characterizes FMR1 alleles, including expanded repeat size and promoter methylation, in molecular testing for fragile X syndrome and related intellectual disability.
Medicare pays $44.89 for 81244 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$44.89
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 81244 covers
FMR1 allele characterization evaluates genetic findings associated with fragile X syndrome and X-linked intellectual disability. The analysis can characterize expanded allele size and promoter methylation status, providing more detail than detection of an abnormal FMR1 allele alone. These results describe allele characteristics relevant to molecular evaluation. Report this code when the performed service characterizes FMR1 alleles, rather than when it only detects an abnormal allele. This characterization supplies detail on the molecular finding for clinical evaluation.
Medicare pays code 81244 through the CLFS at one national amount in every state and locality, without geographic or office-versus-facility adjustment. The 2026 national amount is $44.89, unchanged since 2020. The test is paid only through the CLFS, not the physician fee schedule.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 81244
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 81244. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 81244 with status X (excluded by statute), so the test itself is paid only from the CLFS.
81244 on the lab fee schedule since 2020
81244 · CLFS 2026 Q4 (current)
$44.89
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
81244 compared with similar tests
- 81243FMR1 testingAbnormal allele detection$57.04
- Code 81243 is for detecting an abnormal FMR1 allele. Code 81244 characterizes alleles, including features such as expanded size or promoter methylation status.
- 81234DMPK testExpanded allele detection$137.00
- Code 81234 concerns detection of an abnormal DMPK allele, associated with myotonic dystrophy type 1, rather than FMR1 allele characterization.
- 81239DMPK testingAllele characterization$274.83
- Code 81239 characterizes DMPK alleles. Select the gene-specific service: DMPK for myotonic dystrophy type 1 and FMR1 for fragile X-related testing.
81244 billing questions
How does this differ from code 81243?
Code 81244 characterizes FMR1 alleles, including features such as expanded size and promoter methylation. Code 81243 is for detecting an abnormal FMR1 allele.
What clinical question does this test address?
It characterizes FMR1 findings during molecular evaluation for fragile X syndrome or X-linked intellectual disability.
Is this paid under the physician fee schedule?
No. Medicare pays this test through the CLFS; it is excluded from the physician fee schedule.
Does Medicare use a local payment amount?
No. The CLFS amount is national and applies across localities, with no office-versus-facility payment difference.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 81244 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist